Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver diseases including steatosis, cirrhosis and hepatocellular carcinoma. Currently, there is no vaccine available for prevention of HCV infection due to high degree of strain variation. The current treatment of care, Pegylated interferon α in combination with ribavirin is costly, has significant side effects and fails to cure about half of all infections. The development of in-vitro models such as HCV infection system, HCV sub-genomic replicon, HCV producing pseudoparticles (HCVpp) and infectious HCV virion provide an important tool to develop new antiviral drugs of different targets against HCV. These models also play an important role to study virus lifecycle such as virus entry, endocytosis, replication, release and HCV induced pathogenesis. This review summarizes the most important in-vitro models currently used to study future HCV research as well as drug design.

Highlights

  • Hepatitis C virus (HCV) infection is a serious global health problem that affects 180 million people worldwide and 10 million people in Pakistan [1]

  • HCV causes acute and chronic hepatitis which can eventually lead to permanent liver damage and hepatocellular carcinoma [2]

  • We summarizes the most important in-vitro models currently used to study future HCV research as well as drug design

Read more

Summary

Introduction

HCV infection is a serious global health problem that affects 180 million people worldwide and 10 million people in Pakistan [1]. There is 30-50% variation among viral genotypes and 15-30% among different subtypes while there is 1-5% variation in nucleotide sequence from a single HCV infected patient [5,6]. Initial attempts to established HCV infection used primary cells from humans and chimpanzees. Primary human foetal hepatocytes infected with HCV-containing sera detected the positive strand of virus but the replication is low [14].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call